Table 1 Demographic data of patients with skeletal metastasis from lung cancer
From: Clinical analysis of patients with skeletal metastasis of lung cancer
| Â | Lung cancer survival | Skeletal metastasis survival | ||||
|---|---|---|---|---|---|---|
| Â | Patients, n (%) | Â | Survival (months) | p-value | Survival (months) | p-value |
Age, years | ||||||
  <  60 | 88 (43.6%) |  | 13.8 | 0.009 | 11.0 | 0.002 |
  ≥ 60 | 114 (56.4%) |  | 10.8 | 8.8 | ||
Sex | ||||||
 Male | 126 (62.4%) |  | 12.2 | 0.850 | 9.5 | 0.327 |
 Female | 76 (37.6%) |  | 11.9 | 10.2 | ||
Pathology | ||||||
 Adenocarcinoma | 116 (57.4%) | NSCLC | 12.6 | 0.080 | 10.4 | 0.000 |
 Squamous cell carcinoma | 29 (14.4%) | |||||
 Large cell and other type lung cancer | 20 (9.9%) | |||||
 Small cell lung cancer | 37 (18.3%) | SCLC | 10.0 | 7.2 | ||
Smoking | ||||||
 Smoker | 114 (56.4%) |  | 12.0 | 0.968 | 9.4 | 0.216 |
 Non-smoker | 88 (43.6%) |  | 12.1 | 10.3 | ||
Hypertension | ||||||
 No | 152 (75.2%) |  | 11.9 | 0.545 | 9.6 | 0.421 |
 Yes | 50 (24.8%) |  | 12.7 | 10.2 | ||
Diabetic Mellitus | ||||||
 No | 176 (87.1%) |  | 11.9 | 0.400 | 9.6 | 0.332 |
 Yes | 26 (12.9%) |  | 13.3 | 10.6 | ||
Chronic renal failure | ||||||
 No | 199 (98.5%) |  | 12.1 | 0.960 | 9.7 | 0.370 |
 Yes | 3 (1.5%) |  | 12.3 | 12.3 | ||
Chemotherapy | ||||||
 Do | 192 (95%) |  | 12.6 | 0.000 | 10.1 | 0.000 |
 Undo | 10 (5%) |  | 3.2 | 3.2 | ||
Radiation therapy | ||||||
 Do | 174 (86.1%) |  | 12.5 | 0.062 | 9.9 | 0.147 |
 Undo | 28 (13.9%) |  | 9.5 | 8.5 | ||
Orthopedic surgery | ||||||
 Do | 41 (20.3%) |  | 14.1 | 0.079 | 12.6 | 0.000 |
 Undo | 161 (79.7%) |  | 11.6 | 9.1 | ||